1. Home
  2. KRMD vs MDWD Comparison

KRMD vs MDWD Comparison

Compare KRMD & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$5.77

Market Cap

186.3M

Sector

Health Care

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$19.05

Market Cap

230.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
MDWD
Founded
1980
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.3M
230.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
KRMD
MDWD
Price
$5.77
$19.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$4.83
$37.50
AVG Volume (30 Days)
193.5K
95.0K
Earning Date
11-12-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,070,637.00
$20,932,000.00
Revenue This Year
$23.36
$15.89
Revenue Next Year
$18.63
$25.33
P/E Ratio
N/A
N/A
Revenue Growth
22.12
6.15
52 Week Low
$1.86
$14.14
52 Week High
$6.11
$22.51

Technical Indicators

Market Signals
Indicator
KRMD
MDWD
Relative Strength Index (RSI) 69.43 59.99
Support Level $5.52 $18.71
Resistance Level $6.11 $19.63
Average True Range (ATR) 0.41 0.71
MACD 0.01 0.18
Stochastic Oscillator 76.92 79.22

Price Performance

Historical Comparison
KRMD
MDWD

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: